said its first-quarter profit plunged on generic competition to its blockbuster cholesterol drug Lipitor. The world?s largest drugmaker cut its full-year forecast after the sale of its nutrition business. earned $1.8 billion, 24 cents a share, a 19% decrease from a year ago. Excluding one-time items, made $4.43 billion, or 58 cents per share.